Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/91028
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study |
Author: | Barratt, D. Bandak, B. Klepstad, P. Dale, O. Kaasa, S. Christrup, L. Tuke, J. Somogyi, A. |
Citation: | Pharmacogenetics and Genomics, 2014; 24(4):185-194 |
Publisher: | Lippincott, Williams & Wilkins |
Issue Date: | 2014 |
ISSN: | 1744-6872 1744-6880 |
Statement of Responsibility: | Daniel T. Barratt, Benedikte Bandak, Pål Klepstad, Ola Dale, Stein Kaasa, Lona L. Christrup, Jonathan Tuke, Andrew A. Somogyi |
Abstract: | Abstract not available |
Keywords: | cancer; cytochrome P-450 CYP3A; fentanyl; pain management; pharmacogenetics; pharmacokinetics; transdermal patch |
Rights: | © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins |
DOI: | 10.1097/FPC.0000000000000032 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/1011521 |
Published version: | http://dx.doi.org/10.1097/fpc.0000000000000032 |
Appears in Collections: | Aurora harvest 2 Medical Sciences publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.